Marshall Wace’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
65,871
-268,207
| -80% | -$9.75M | ﹤0.01% | 1366 |
|
|
2025
Q1 | $12.1M | Sell |
334,078
-717,495
| -68% | -$26M | 0.02% | 644 |
|
|
2024
Q4 | $44.2M | Buy |
1,051,573
+229,561
| +28% | +$9.66M | 0.05% | 289 |
|
|
2024
Q3 | $45.7M | Sell |
822,012
-311,088
| -27% | -$17.3M | 0.06% | 281 |
|
|
2024
Q2 | $46.6M | Buy |
1,133,100
+164,110
| +17% | +$6.74M | 0.06% | 261 |
|
|
2024
Q1 | $45.2M | Sell |
968,990
-520,496
| -35% | -$24.3M | 0.07% | 249 |
|
|
2023
Q4 | $71.2M | Buy |
1,489,486
+548,723
| +58% | +$26.2M | 0.12% | 147 |
|
|
2023
Q3 | $33.5M | Buy |
940,763
+14,126
| +2% | +$504K | 0.07% | 278 |
|
|
2023
Q2 | $42.7M | Buy |
926,637
+21,112
| +2% | +$974K | 0.08% | 236 |
|
|
2023
Q1 | $36.3M | Buy |
905,525
+570,100
| +170% | +$22.9M | 0.08% | 253 |
|
|
2022
Q4 | $15.5M | Buy |
335,425
+254,711
| +316% | +$11.8M | 0.04% | 502 |
|
|
2022
Q3 | $3.34M | Sell |
80,714
-270,936
| -77% | -$11.2M | 0.01% | 1356 |
|
|
2022
Q2 | $21M | Sell |
351,650
-33,803
| -9% | -$2.02M | 0.04% | 403 |
|
|
2022
Q1 | $28M | Buy |
385,453
+151,223
| +65% | +$11M | 0.05% | 350 |
|
|
2021
Q4 | $19.7M | Buy |
234,230
+204,288
| +682% | +$17.2M | 0.04% | 451 |
|
|
2021
Q3 | $2.7M | Sell |
29,942
-5,587
| -16% | -$504K | 0.01% | 1081 |
|
|
2021
Q2 | $3.39M | Buy |
+35,529
| New | +$3.39M | 0.02% | 908 |
|
|
2021
Q1 | – | Sell |
-26,014
| Closed | -$3.6M | – | 2446 |
|
|
2020
Q4 | $3.6M | Buy |
+26,014
| New | +$3.6M | 0.02% | 640 |
|
|
2016
Q1 | – | Sell |
-29,656
| Closed | -$3.33M | – | 1167 |
|
|
2015
Q4 | $3.33M | Sell |
29,656
-44,337
| -60% | -$4.97M | 0.03% | 469 |
|
|
2015
Q3 | $7.13M | Buy |
73,993
+14,044
| +23% | +$1.35M | 0.09% | 231 |
|
|
2015
Q2 | $6.14M | Sell |
59,949
-62,664
| -51% | -$6.42M | 0.08% | 265 |
|
|
2015
Q1 | $7.61M | Buy |
+122,613
| New | +$7.61M | 0.1% | 242 |
|